RAPID THERAPEUTIC SCIENCE LABORATORIES, INC.

Communiqués Rapid Therapeutic Science Laboratories, Inc.

Actions

RTSL

US7534312043

Produits pharmaceutiques

Marché Fermé - OTC Markets Autres places de cotation 19:54:12 30/06/2026			Varia. 5j.	Varia. 1 janv.
0,000100 ^USD	-.--%		-.--%	-93,33%

14/08/23	Rapid Therapeutic Science Laboratories, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2023	CI
12/05/23	Rapid Therapeutic Science Laboratories, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2023	CI

Communiqués

06/12/23	Rapid Therapeutic Science Laboratories : Change in Certifying Accountants - Form 8-K	PU
30/03/23	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
21/03/23	White House Office of Management and Budget review on Cannabis-Derived Products confirms Rapid Therapeutic Science Laboratories’ Long-Term Strategy	AQ
13/12/22	Rapid Therapeutic Science Laboratories Updates Patents	AQ
10/11/22	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
12/08/22	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
26/07/22	Rapid Therapeutic Science Laboratories File S1 and completes Mid-Year Strategy Review	AQ
31/05/22	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
11/05/22	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
28/04/22	Rapid Therapeutic Science Laboratories to Attend the Respiratory Drug Delivery (RDD) 2022 Conference	AQ
31/03/22	Rapid Therapeutic Science Laboratories Announces 1-for-25 Reverse Stock Split	AQ
16/03/22	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
01/02/22	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
21/01/22	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
18/01/22	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
02/12/21	Rapid Therapeutic Science Laboratories to Present at the Benzinga Global Small Cap Conference	GL
02/12/21	Rapid Therapeutic Science Laboratories to Present at the Benzinga Global Small Cap Conference	GL
12/11/21	Rapid Therapeutic Science Laboratories to Present at the Q4 Investor Summit Conference	AQ
11/11/21	Rapid Therapeutic Science Laboratories Secures Upgraded Laboratory and Manufacturing Facility	AQ
10/11/21	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
02/11/21	Rapid Therapeutic Science Laboratories Adds Two Independent Directors to Company’s Board	GL
26/10/21	Rapid Therapeutic Science Laboratories to Present at the Benzinga Global Small Cap Conference	AQ
12/10/21	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
07/10/21	Rapid Therapeutic Science Laboratories : Postpones Shareholder Update Conference Call	GL
06/10/21	Rapid Therapeutic Science Laboratories : to Present at the LD Micro Main Event Conference	AQ